Nestle deal with Valeant ‘skin tight’

Comment on this story

Nestlé had tightened its grip on the medical skin treatment market by finalising a deal with Canada’s Valeant Pharmaceuticals, the Swiss food firm said yesterday. The $1.4 billion (R15bn) deal was announced in May but needed a green light from regulators to be complete. North America accounts for more than half of the global medical aesthetics market, data show. Galderma, a Nestlé and L’Oréal joint venture, became fully owned by Nestlé on Tuesday after the Swiss group completed its acquisition of L’Oréal’s 50 percent stake. – Sapa-AFP

sign up

Comment Guidelines

  1. Please read our comment guidelines.
  2. Login and register, if you haven’ t already.
  3. Write your comment in the block below and click (Post As)
  4. Has a comment offended you? Hover your mouse over the comment and wait until a small triangle appears on the right-hand side. Click triangle () and select "Flag as inappropriate". Our moderators will take action if need be.

  5. Verified email addresses: All users on Independent Media news sites are now required to have a verified email address before being allowed to comment on articles. You are only required to verify your email address once to have full access to commenting on articles. For more information please read our comment guidelines